A single-dose, double-blind, crossover, placebo- and moxifloxacin (open-label)-controlled study of the effects of lecozotan SR [sustained release] on cardiac repolarization in healthy adult subjects

Trial Profile

A single-dose, double-blind, crossover, placebo- and moxifloxacin (open-label)-controlled study of the effects of lecozotan SR [sustained release] on cardiac repolarization in healthy adult subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Jan 2010

At a glance

  • Drugs Lecozotan; Moxifloxacin
  • Indications Alzheimer's disease; Bacterial infections
  • Focus Adverse reactions
  • Sponsors Wyeth
  • Most Recent Events

    • 10 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top